Table 2. Summary statistics of analytes by sample round for adults (51 subjects, 135 paired urine and serum samples).

Analytes	Round 1 (n=47)		Round 2 (n=46)		Round 3 (n=42)
	GM (GSD)	Range	GM (GSD)	Range	GM (GSD)	Range
Urinary
DPHP (ng/ml)
Uncorrecteda	1.74 (3.29)	0.12 – 162	0.99 (3.77)	0.14 – 62	1.42 (3.00)	0.15 – 25
SG-correctedb	2.99 (2.98)	0.39 – 142	1.80 (3.30)	0.17 – 99	2.11 (2.48)b	0.46 – 25
Iodide (μg/L)
Uncorrecteda	130 (2.19)	27 – 890	102 (2.33)	11 – 382	148 (1.92)	32 – 660
SG-correctedb, d	223 (1.62)	78.4 – 815	186 (1.70)	30.3 – 519	240 (1.61)	98.5 – 671
Specific Gravityc	1.016 (0.007)	1.004 – 1.028	1.016 (0.009)	1.003 – 1.035	1.016 (0.007)	1.0001 – 1.027
Serum
Hormones
TT4 (μg/dL)c	7.30 (1.32)	3.18 – 9.63	7.30 (1.42)	3.9 – 10.2	7.13 (1.24)	4.74 – 9.71
fT4 (ng/dL)	1.23 (1.16)	0.93 – 2.09	1.20 (1.19)	0.95 – 2.2	1.19 (1.15)	0.96 – 1.61
TT3 (ng/mL)	1.08 (1.17)	0.78 – 1.54	1.06 (1.18)	0.8 – 1.44	1.06 (1.18)	0.84 – 1.54
TSH (μIU/mL)	0.71 (1.78)	0.17 – 2.65	0.77 (1.81)	0.16 – 2.27	0.88 (1.98)	0.17 – 4.77
BDE-47 (ng/g lipid)e	9.52 (2.87)	0.60 – 151	10.26 (2.72)	1.30 – 149	7.93 (2.62)	0.90 – 99

GM, geometric mean; GSD, geometric standard deviation;

^aUncorrected for urinary dilution

^bSG-corrected for urinary dilution

^cArithmetic mean and standard deviation

^d1 sample excluded during round 3 due to extreme urinary dilution (SG = 1.0001)

^e1 sample excluded during round 3 due to suspected contamination